Indications | Early benefit assessments by indication (N) | Addenda for early benefit assessments by indication (N) | Proportion of addenda within indication (%) | Overall proportion by indication (%) | Subgroups in addenda by indication (N) | Overall proportion of subgroups by indication (%) |
---|---|---|---|---|---|---|
Oncology | 96 | 40 | 42% | 44% | 56 | 45% |
Metabolic disorders | 40 | 16 | 40% | 18% | 18 | 15% |
Infectious diseases | 25 | 12 | 48% | 13% | 22 | 18% |
Others | 39 | 11 | 28% | 12% | 16 | 13% |
Neurology | 16 | 7 | 44% | 8% | 7 | 6% |
Respiratory diseases | 13 | 4 | 31% | 5% | 5 | 4% |